Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

Measuring the Incidence of Hospital Readmissions, Caused by Adverse Drug Events (ADE) Due to Anticoagulants in Vzw Jessa Hospital (Belgium)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02074085

Enrollment

450

Registered

2014-02-28

Start date

2014-03-31

Completion date

Unknown

Last updated

2014-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADE's Due to Anticoagulants, Incidence of Readmissions

Brief summary

An ADE is defined as harm caused by a drug or the inappropriate use of a drug. Retrospective record reviews in several countries have shown that anticoagulants frequently lead to hospital readmissions. In this study a hospital readmission is defined as an admission to the emergency department of the Jessa hospital. The objective of this study is to determine the incidence of one week and 30-day readmissions caused by (preventable) ADE's due to anticoagulants.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Patients who received an anticoagulant on their last day of admission 2. Patients who were readmitted within 30 days 3. Patients who were diagnosed using the pathology registration of the emergency department of the Jessa hospital

Exclusion criteria

1. Patients who didn't receive an anticoagulant on their last day of admission 2. Patients who were not readmitted within 30 days 3. Patients who were not diagnosed using the pathology registration of the emergency department of the Jessa hospital 4. Patients with missing data

Design outcomes

Primary

Measure	Time frame
incidence of readmissions within one week caused by ADE's due to anticoagulants	up to one week
incidence of readmissions within 30 days caused by ADE's due to anticoagulants	up to 1 month
incidence of preventable ADE's leading to readmission	week 1, month 1

Countries

Belgium

Contacts

Primary ContactKristel Marquet, Drs.

kristel.marquet@uhasselt.be3211268531

Backup ContactMartijn Droogmans, Ap.

martijn.droogmas@jessazh.be

Outcome results